RELATIONSHIP OF MOUNTAIN-SICKNESS TO PHYSICAL-FITNESS AND EXERCISE INTENSITY DURING ASCENT

被引：23

作者：

BIRCHER, HP ^{[1
]}

EICHENBERGER, U ^{[1
]}

MAGGIORINI, M ^{[1
]}

OELZ, O ^{[1
]}

BARTSCH, P ^{[1
]}

机构：

[1] UNIV HEIDELBERG,MED KLIN,SPORT & LEISTUNGSMED ABT 17,HOSP STR 3,D-69115 HEIDELBERG,GERMANY

来源：

JOURNAL OF WILDERNESS MEDICINE | 1994年 / 5卷 / 03期

关键词：

ACUTE MOUNTAIN SICKNESS; HIGH-ALTITUDE PULMONARY EDEMA; EXERCISE; SUSCEPTIBILITY; HEART RATE; WORK CAPACITY;

D O I：

10.1580/0953-9859-5.3.302

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

The purpose of the study was to investigate whether susceptibility to acute mountain sickness (AMS) and high-altitude pulmonary edema (HAPE) is related to differences of physical fitness and/or the level of exercise during ascent. Work capacity at a heart rate of 170 min-1 (PWC170) was assessed on a bicycle ergometer prior to high-altitude exposure, and the heart rate was continuously registered during the ascent from 3610 to 4559 m in 41 mountaineers. During the subsequent stay of 3 days at 4559 m, 12 subjects developed AMS, 13 subjects showed radiographic evidence of HAPE, and 16 subjects remained without significant illness. PWC170 (group means between 238 and 247 W) and hear-t rate during ascent (group means between 134 and 141 min-1) did not significantly differ between these groups. PWC170 correlated negatively with two independent symptoms scores (clinical score, environmental symptom questionnaire) on day 3 at 4559 m, whereas heart rate during ascent correlated positively only with clinical score on days 2 and 3 at 4559 m. Correlations, however, were minor, with correlation coefficients of r = 0.32-0.43 (p < 0.05-0.01). These results indicate that physical fitness or exercise intensity during ascent were of minor importance for the development of AMS and HAPE in our subjects.

引用

页码：302 / 311

页数：10

共 25 条

[1]

West J.B., Boyer S.J., Graber D.J., Hackett P.H., Maret K.H., Milledge J.S., Peters R.M., Pizzo C.J., Samaja M., Sarnquist F.H., Schoene R.B., Winslow R.M., Maximal exercise at extreme altitudes on Mount Everest, J Appl Physiol, 55, pp. 688-698, (1983)

[2]

Wagner P.D., Gale G.G., Moon R.E., Torre-Bueno J.R., Stolp B.W., Saltzman H.A., Pulmonary gas exchange in humans exercising at sea level and simulated altitude, J Appl Physiol, 61, pp. 260-270, (1986)

[3]

Bartsch P., Maggiorini M., Schobersberger W., Shaw S., Rascher W., Girard J., Weidmann P., Oelz O., Enhanced ecercise-induced rise of aldosterone and vasopressin preceding mountain sickness, J Appl Physiol, 71, pp. 136-143, (1991)

[4]

Reeves J.T., Groves B.M., Sutton J.R., Wagner P.D., Cymerman A., Malconian M.K., Rock P.B., Young P.M., Houston C.S., Operation Everest II: preservation of cardiac function at extreme altitude, J Appl Physiol, 63, pp. 531-539, (1987)

[5]

Johnson T.S., Rock P.B., Acute mountain sickness, N Engl J Med, 319, pp. 841-845, (1988)

[6]

Bartsch P., Vock P., Maggiorini M., Franciolli M., Fretz C., Schobersberger W., Mairbaurl H., Oelz O., Respiratory symtomps, radiographic and physiologic correlations at high altitude, (1990)

[7]

Bartsch P., Shaw S., Franciolli M., Gnadinger M.P., Weidmann P., Atrial natriuretic peptide in acute mountain sickness, J Appl Physiol, 65, pp. 1929-1937, (1988)

[8]

Hackett P.H., Rennie D., Hofmeister S.E., Grover R.F., Grover E.B., Reeves J.T., Fluid retention and relative hypoventilation in acute mountain sickness, Respiration, 43, pp. 321-329, (1982)

[9]

Hultgren H.N., Grover R.F., Hartley L.H., Abnormal circulatory responses to high altitude in subjects with a previous history of high-altitude pulmonary edema, Circulation, 44, pp. 759-770, (1971)

[10]

Oelz O., Maggiorini M., Ritter M., Waber U., Jenni R., Vock P., Bartsch P., Nifedipine for high altitude pulmonary oedema, Lancet, 2, pp. 1241-1244, (1989)

← 1 2 3 →